Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis
- PMID: 37752476
- PMCID: PMC10521426
- DOI: 10.1186/s12885-023-11406-z
Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis
Abstract
Objective: We aimed to evaluate the clinical efficacy and prognostic significance of intensity-modulated radiotherapy (IMRT)-based salvage concurrent chemoradiotherapy (CCRT) for patients with locoregional recurrence cervical cancer after radical hysterectomy and evaluated two salvage radiotherapy modes-regional RT (involved-field RT combined with regional lymph nodes) and local RT (involved-field RT).
Methods: Patients were enrolled retrospectively from January 2011 to January 2022 in three medical centers. Clinical outcomes were analyzed using the Kaplan-Meier method and a Cox proportional hazards model. Propensity score (PS) matching analysis was used to compare the two RT groups.
Results: There were 72 patients underwent IMRT-based salvage CCRT. The 5-year overall survival and progression-free survival rates were 65.9% and 57.6%, respectively. Univariate analysis showed that patients with stump recurrence, a lower systemic inflammation response index (SIRI), only one metastatic lesion, and received regional RT had better prognosis than their counterparts. In multivariate analysis, recurrence site was the independent prognostic factor of OS, and SIRI was that of PFS. After PS matching, there were 15 patients each in the regional RT group and local RT group. The 5-year OS rate of regional RT group was better than that of local RT group (90.9 vs. 42.4, p = 0.021). However, there was no significant difference between them in terms of PFS rate (47.1 vs. 38.1, p = 0.195).
Conclusion: Locoregional recurrent cervical cancer treated with IMRT-based salvage therapy has a good prognosis. Recurrence site and SIRI were independent prognostic factors. Regional RT may be a better option for patients with locoregional recurrent.
Keywords: Cervical cancer; Prognosis; Radiotherapy; Recurrence; Systemic inflammation response index.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.Radiat Oncol. 2019 Dec 26;14(1):236. doi: 10.1186/s13014-019-1442-6. Radiat Oncol. 2019. PMID: 31878944 Free PMC article.
-
[Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].Zhonghua Zhong Liu Za Zhi. 2018 Jun 23;40(6):462-466. doi: 10.3760/cma.j.issn.0253-3766.2018.06.012. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29936774 Chinese.
-
Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.Strahlenther Onkol. 2017 Jul;193(7):534-542. doi: 10.1007/s00066-017-1122-0. Epub 2017 Mar 29. Strahlenther Onkol. 2017. PMID: 28357468 English.
-
Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer.Gynecol Oncol. 2018 Nov;151(2):208-214. doi: 10.1016/j.ygyno.2018.08.029. Epub 2018 Sep 6. Gynecol Oncol. 2018. PMID: 30195468
-
[Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].Zhonghua Fu Chan Ke Za Zhi. 2018 Apr 25;53(4):248-256. doi: 10.3760/cma.j.issn.0529-567x.2018.04.008. Zhonghua Fu Chan Ke Za Zhi. 2018. PMID: 29747270 Chinese.
Cited by
-
Prognostic value of systemic inflammation response index in cervical cancer: a meta-analysis.Future Sci OA. 2025 Dec;11(1):2526990. doi: 10.1080/20565623.2025.2526990. Epub 2025 Jul 6. Future Sci OA. 2025. PMID: 40619858 Free PMC article. Review.
-
PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study.J Hepatocell Carcinoma. 2024 Jun 18;11:1157-1170. doi: 10.2147/JHC.S457527. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 38911293 Free PMC article.
-
Interpretable machine learning model based on the systemic inflammation response index and ultrasound features can predict central lymph node metastasis in cN0T1-T2 papillary thyroid carcinoma.Gland Surg. 2023 Nov 24;12(11):1485-1499. doi: 10.21037/gs-23-349. Epub 2023 Nov 17. Gland Surg. 2023. PMID: 38107491 Free PMC article.
References
-
- Kong TW, et al. Prognostic factors influencing pelvic, extra-pelvic, and intraperitoneal recurrences in lymph node-negative early-stage cervical cancer patients following radical hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2020;252:94–9. - PubMed
-
- Wenzel HHB, et al. Survival of patients with early-stage cervical cancer after abdominal or laparoscopic radical hysterectomy: a nationwide cohort study and literature review. Eur J Cancer. 2020;133:14–21. - PubMed